Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Clinical trial NCT07700979 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07700979
- Sponsor
- Akeso
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-20
- Primary completion
- 2029-08-18
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.